Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 1;328(2):H327-H332.
doi: 10.1152/ajpheart.00815.2024. Epub 2025 Jan 7.

Short-term estradiol administration does not restore endothelin-B receptor-mediated vasodilation in postmenopausal women

Affiliations

Short-term estradiol administration does not restore endothelin-B receptor-mediated vasodilation in postmenopausal women

Virginia R Nuckols et al. Am J Physiol Heart Circ Physiol. .

Abstract

The endothelin-B receptor (ETBR) mediates vasodilation in young women, an effect that is absent in postmenopausal women. We have previously demonstrated that ETBR-mediated vasodilation is regulated by estradiol (E2) in young women; however, the impact of E2 on ETBR function in postmenopausal women remains unknown. Accordingly, the objective of this study was to test the hypothesis that E2 exposure restores ETBR-mediated dilation in postmenopausal women. Ten healthy postmenopausal women (55 ± 2 yr of age, 5 ± 3 years since menopause) completed the study. E2 was administered by transdermal patch for 7 days (0.1 mg/day, Vivelle-Dot patch). Vasodilation in the cutaneous microcirculation (microvascular endothelial function) was measured via local heating (42°C) using laser Doppler flowmetry combined with intradermal microdialysis perfusions of lactated Ringer's (control) and ETBR antagonist (BQ-788, 300 nM) at baseline and after E2 administration. There was no effect of E2 on ETBR function [hormone × site, F(1,9) = 0.77, P = 0.40]. These data demonstrate that in contrast to findings in premenopausal women, E2 administration does not restore ETBR function in postmenopausal women.NEW & NOTEWORTHY The vascular endothelial endothelin-B receptor (ETBR) mediates vasodilation in premenopausal women, an effect modulated by estradiol. ETBR-mediated vasodilation is lost in postmenopausal women, but the effect of exogenous estradiol administration on ETBR function in postmenopausal women is not known. During estradiol administration, ETBR blockade did not affect cutaneous microvascular vasodilatory response to local heating. We demonstrate that exogenous estradiol administration does not restore ETBR-mediated vasodilation in postmenopausal women.

Keywords: endothelial function; endothelin; estrogen; menopause; skin blood flow.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Cutaneous vascular conductance expressed as a percent of maximal vasodilation (%CVCmax) during local heating and perfusion of lactated Ringer’s (control) and ETBR blockade (BQ-788) at baseline (grey bar) and with estradiol (E2) administration (white bar). Data are results of two-way within-group ANOVA (hormone by site) presented as means (bars) with individual values. Labels are mean±SD.

Similar articles

Cited by

References

    1. El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, Limacher MC, Manson JE, Stefanick ML, and Allison MA. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation 142: e506–e532, 2020. - PubMed
    1. Ras RT, Streppel MT, Draijer R, and Zock PL. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. International journal of cardiology 168: 344–351, 2013. - PubMed
    1. Moreau KL, Stauffer BL, Kohrt WM, and Seals DR. Essential role of estrogen for improvements in vascular endothelial function with endurance exercise in postmenopausal women. The Journal of Clinical Endocrinology & Metabolism 98: 4507–4515, 2013. - PMC - PubMed
    1. Gohar EY, Giachini FR, Pollock DM, and Tostes RC. Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases. Life sciences 159: 20–29, 2016. - PMC - PubMed
    1. Thorin E, and Clozel M. The cardiovascular physiology and pharmacology of endothelin-1. Advances in pharmacology 60: 1–26, 2010. - PMC - PubMed

LinkOut - more resources